# A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

> **NCT07038720** · PHASE1 · RECRUITING · sponsor: **Usynova Pharmaceuticals Ltd.** · enrollment: 124 (estimated)

## Conditions studied

- Plaque Psoriasis
- Healthy Volunteer

## Interventions

- **DRUG:** UA026
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07038720
- **Lead sponsor:** Usynova Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-08
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07038720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07038720, "A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07038720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*